Metraipolis › archive › dc_b5bbd0033b4a
Pharmacological strategies to overcome immune checkpoint inhibitor resistance in non-small cell lung cancer — Europe PMC PMID:41584608
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41584608
- DOI
- 10.3389/fonc.2025.1665239
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T23:51:36.369Z
- SHA-256 of the archived text
eb38912c9e95f376edb72cf413b0d48d4e8e09e54dbd1a0b33de56296fd56aad- Stable URL of this page
https://metraipolis.com/documento/dc_b5bbd0033b4a
How to cite
Pharmacological strategies to overcome immune checkpoint inhibitor resistance in non-small cell lung cancer — Europe PMC PMID:41584608 — Europe PMC (en), https://europepmc.org/article/MED/41584608 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b5bbd0033b4a (Metraipolis archive dc_b5bbd0033b4a, sha256 eb38912c9e95f376edb72cf413b0d48d4e8e09e54dbd1a0b33de56296fd56aad)
BibTeX
@misc{dcb5bbd0033b4a,
title = {Pharmacological strategies to overcome immune checkpoint inhibitor resistance in non-small cell lung cancer — Europe PMC PMID:41584608},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41584608},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b5bbd0033b4a; sha256 eb38912c9e95f376edb72cf413b0d48d4e8e09e54dbd1a0b33de56296fd56aad},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41584608. Agents can read the archived copy with the MCP tool read_document.